1 |
Mann DL, Zipes DP, Libby P, et al. Braunwald's Heart Disease: a Textbook of Cardiovascular Medicine [M]. Philadelphia: Elsevier Saunders, 2015.
|
2 |
Santos JRU, Brofferio A, Viana B, et al. Catecholamine-induced cardiomyopathy in pheochromocytoma: how to manage a rare complication in a rare disease [J]. Horm Metab Res, 2019, 51(7): 458-469.
|
3 |
Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2014, 99(6): 1915-1942.
|
4 |
Cohen DL, Fraker D, Townsend RR. Lack of symptoms in patients with histologic evidence of pheochromocytoma: a diagnostic challenge [J]. Ann N Y Acad Sci, 2006, 1073: 47-51.
|
5 |
Mobine HR, Baker AB, Wang L, et al. Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors [J]. Circ Heart Fail, 2009, 2(2): 121-128.
|
6 |
Giavarini A, Chedid A, Bobrie G, et al. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma [J]. Heart, 2013, 99(19): 1438-1444.
|
7 |
Sauneuf B, Chudeau N, Champigneulle B, et al. Pheochromocytoma crisis in the ICU: a French multicenter cohort study with emphasis on rescue extracorporeal membrane oxygenation [J]. Crit Care Med, 2017, 45(7): e657-e665.
|
8 |
Matteucci M, Kowalewski M, Fina D, et al. Extracorporeal life support for phaeochromocytoma-induced cardiogenic shock: a systematic review [J]. Perfusion, 2020, 35(suppl 1): 20-28.
|
9 |
Neumann HPH, Young WFJr, Eng C. Pheochromocytoma and paraganglioma [J]. N Engl J Med, 2019, 381(6): 552-565.
|
10 |
Müller G, Saint F, Hamy A, et al. Pheochromocytoma revealed by acute heart failure. When should we operate? Presented at the ESES Congress, Gothenburg May 25-26, 2012 [J]. Langenbecks Arch Surg, 2013, 398(5): 729-733.
|
11 |
Grinda JM, Bricourt MO, Salvi S, et al. Unusual cardiogenic shock due to pheochromocytoma: recovery after bridge-to-bridge (extracorporeal life support and DeBakey ventricular assist device) and right surrenalectomy [J]. J Thorac Cardiovasc Surg, 2006, 131(4): 913-914.
|
12 |
Chao A, Yeh YC, Yen TS, et al. Phaeochromocytoma crisis--a rare indication for extracorporeal membrane oxygenation [J]. Anaesthesia, 2008, 63(1): 86-88.
|
13 |
Suh IW, Lee CW, Kim YH, et al. Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation (ECMO) in pheochromocytoma [J]. J Korean Med Sci, 2008, 23(2): 350-354.
|
14 |
Huang JH, Huang SC, Chou NK, et al. Extracorporeal membrane oxygenation rescue for cardiopulmonary collapse secondary to pheochromocytoma: report of three cases [J]. Intensive Care Med, 2008, 34(8): 1551-1552.
|
15 |
Wu XM, Chen JJ, Wu CK, et al. Pheochromocytoma presenting as acute myocarditis with cardiogenic shock in two cases [J]. Intern Med, 2008, 47(24): 2151-2155.
|
16 |
Ritter S, Guertler T, Meier CA, et al. Cardiogenic shock due to pheochromocytoma rescued by extracorporeal membrane oxygenation [J]. Interact Cardiovasc Thorac Surg, 2011, 13(1): 112-113.
|
17 |
Sheinberg R, Gao WD, Wand G, et al. Case 1-2012. A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management [J]. J Cardiothorac Vasc Anesth, 2012, 26(1): 161-165.
|
18 |
Banfi C, Juthier F, Ennezat PV, et al. Central extracorporeal life support in pheochromocytoma crisis [J]. Ann Thorac Surg, 2012, 93(4): 1303-1305.
|
19 |
Sojod G, Diana M, Wall J, et al. Successful extracorporeal membrane oxygenation treatment for pheochromocytoma-induced acute cardiac failure [J]. Am J Emerg Med, 2012, 30(6): 1017.e1-3.
|
20 |
Kaese S, Schülke C, Fischer D, et al. Pheochromocytoma-induced takotsubo-like cardiomyopathy and global heart failure with need for extracorporal life support [J]. Intensive Care Med, 2013, 39(8): 1473-1474.
|
21 |
Flam B, Broomé M, Frenckner B, et al. Pheochromocytoma-induced inverted takotsubo-like cardiomyopathy leading to cardiogenic shock successfully treated with extracorporeal membrane oxygenation [J]. J Intensive Care Med, 2015, 30(6): 365-372.
|
22 |
Mita K, Tsugita K, Yasuda Y, et al. A successfully treated case of cardiac arrest after Caesarean section complicated by pheochromocytoma crisis and amniotic fluid embolism [J]. J Anesth, 2017, 31(1): 140-143.
|
23 |
van Zwet CJ, Rist A, Haeussler A, et al. Extracorporeal membrane oxygenation for treatment of acute inverted takotsubo-like cardiomyopathy from hemorrhagic pheochromocytoma in late pregnancy [J]. A A Case Rep, 2016, 7(9): 196-199.
|
24 |
Van Dang S, Hamy A, Hubert N, et al. Cardiogenic shock induced by a voluminous phaeochromocytoma rescued by concomitant extracorporeal life support and open left adrenalectomy [J]. Eur J Cardiothorac Surg, 2016, 50(4): 782-783.
|
25 |
Hekimian G, Kharcha F, Bréchot N, et al. Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock [J]. Ann Intensive Care, 2016, 6(1): 117.
|
26 |
Bouabdallaoui N, Bouchard D, Jolicoeur EM, et al. Extracorporeal membrane oxygenation in pheochromocytoma-induced cardiogenic shock [J]. Asian Cardiovasc Thorac Ann, 2018, 26(4): 314-316.
|
27 |
Haake H, Grün-Himmelmann K, Kania U, et al. Treatment of an uncommon case of a cardiogenic shock : Simultaneous use of a VA-ECMO and an Impella-CP® [J]. Med Klin Intensivmed Notfmed, 2018, 113(2): 131-134.
|
28 |
Martin-Villen L, Corcia-Palomo Y, Escalona-Rodriguez S, et al. Extracorporeal membrane oxygenation support in a patient with pheochromocytoma stress myocardyopathy [J]. Med Intensiva (Engl Ed), 2018, 42(9): 566-568.
|
29 |
Garla VV, Gosi S, Kanduri S, et al. A case of catecholamine-induced cardiomyopathy treated with extracorporeal membrane oxygenation [J]. BMJ Case Rep, 2019, 12(9): e230196.
|
30 |
Mierke J, Loehn T, Linke A, et al. Reverse takotsubo cardiomyopathy- life-threatening symptom of an incidental pheochromocytoma: a case report [J]. Eur Heart J Case Rep, 2019, 3(4): 1-6.
|
31 |
Kiamanesh O, Vu EN, Webber DL, et al. Pheochromocytoma-induced takotsubo syndrome treated with extracorporeal membrane oxygenation: beware of the apical sparing pattern [J]. JACC Case Rep, 2019, 1(2): 85-90.
|
32 |
Su Z, Wang Y, Fei H. Takotsubo-like cardiomyopathy in pheochromocytoma [J]. CASE (Phila), 2019, 3(4): 157-161.
|
33 |
Faria BMM, Português J, Roncon-Albuquerque RJr, et al. Inverted takotsubo syndrome complicated with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation in a patient with bilateral pheochromocytoma: a case report [J]. Eur Heart J Case Rep, 2020, 4(2): 1-5.
|
34 |
Dominedò C, D'Avino E, Martinotti A, et al. A rare pheochromocytoma complicated by cardiogenic shock and posterior reversible encephalopathy syndrome: case report [J]. Eur Heart J Case Rep, 2021, 5(2): ytaa513.
|
35 |
Park S, Kim M, Lee DI, et al. Successful extracorporeal membrane oxygen-ation treatment of catecholamine-induced cardiomyopathy-associated pheochro-mocytoma [J/OL]. Acute Crit Care, 2022. Epub ahead of print.
|
36 |
Attisani M, Pocar M, Brenna D, et al. Extracorporeal membrane oxygenation with ventricular unloading allows for immediate adrenergic blockage in pheochromocytoma-induced cardiogenic shock [J]. J Cardiothorac Vasc Anesth, 2021, 35(10): 3039-3041.
|
37 |
Myatt T, Barker M. Pheochromocytoma leading to multiorgan failure in a pregnant patient: a case report [J]. Clin Pract Cases Emerg Med, 2021, 5(4): 394-398.
|
38 |
Wang T, Xu Q, Jiang X. Successful extracorporeal membrane oxygenation resuscitation of patient with cardiogenic shock induced by phaeochromocytoma crisis mimicking hyperthyroidism: a case report [J]. Open Life Sci, 2021, 16(1): 746-751.
|
39 |
Luo S, Cui Q, Wang D. Case report: surgical intervention under pheochromocytoma multisystem crisis: timing and approach [J]. Front Oncol, 2022, 12: 908039.
|
40 |
Lyu T, Niu J, Liu Z, et al. Case report: early resection of pheochromocytoma in a patient with cardiogenic shock due to pheochromocytoma-induced cardiomyopathy with extracorporeal life support [J]. Front Cardiovasc Med, 2022, 9: 788644.
|
41 |
Shah MH, Goldner WS, Benson AB, et al. Neuroendocrine and adrenal tumors, version 2. 2021, NCCN clinical practice guidelines in oncology [J]. J Natl Compr Canc Netw, 2021, 19(7): 839-868.
|
42 |
Wittstein IS. Stress cardiomyopathy: a syndrome of catecholamine-mediated myocardial stunning [J]. Cell Mol Neurobiol, 2012, 32(5): 847-857.
|
43 |
Prejbisz A, Lenders JW, Eisenhofer G, et al. Cardiovascular manifestations of phaeochromocytoma [J]. J Hypertens, 2011, 29(11): 2049-2060.
|
44 |
中华医学会内分泌学分会. 嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版) [J]. 中华内分泌代谢杂志, 2020, 36(9): 737-750.
|
45 |
Harrington JL, Farley DR, van Heerden JA, et al. Adrenal tumors and pregnancy [J]. World J Surg, 1999, 23(2): 182-186.
|
46 |
Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy [J]. Br J Surg, 2013, 100(2): 182-190.
|
47 |
Sarathi V, Lila AR, Bandgar TR, et al. Pheochromocytoma and pregnancy: a rare but dangerous combination [J]. Endocr Pract, 2010, 16(2): 300-309.
|
48 |
Neal JR, Quintana E, Pike RB, et al. Using daily plasma-free hemoglobin levels for diagnosis of critical pump thrombus in patients undergoing ECMO or VAD support [J]. J Extra Corpor Technol, 2015, 47(2): 103-108.
|
49 |
Diehl A, Gantner D. Pump head thrombosis in extracorporeal membrane oxygenation (ECMO) [J]. Intensive Care Med, 2018, 44(3): 376-377.
|